Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-01 Sale | 2026-04-03 4:10 pm | Dyne Therapeutics Inc. | DYN | Lucera Erick Chief Financial Officer | 5,727 | $18.64 | $106,751 | 125,373 (Direct) | View |
| 2026-03-30 Purchase | 2026-04-01 4:27 pm | Dyne Therapeutics Inc. | DYN | Posner Brian S Director | 2,000 | $17.08 | $34,160 | 15,500 (Direct) | View |
| 2026-03-11 Purchase | 2026-03-13 4:46 pm | Dyne Therapeutics Inc. | DYN | Posner Brian S Director | 2,000 | $19.35 | $38,700 | 13,500 (Direct) | View |
| 2026-03-11 Sale | 2026-03-13 4:35 pm | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 129,672 | $19.52 | $2,530,562 | 4,644,386 (Indirect) | View |
| 2026-03-09 Sale | 2026-03-11 5:27 pm | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 688,788 | $19.09 | $13,149,314 | 4,774,058 (Indirect) | View |
| 2026-03-06 Purchase | 2026-03-10 5:33 pm | Dyne Therapeutics Inc. | DYN | Posner Brian S Director | 3,000 | $15.06 | $45,180 | 11,500 (Direct) | View |
| 2026-03-05 Sale | 2026-03-06 4:10 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 148 | $14.9 | $2,205 | 154,581 (Direct) | View |
| 2026-03-05 Sale | 2026-03-06 4:09 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 904 | $14.9 | $13,470 | 171,606 (Direct) | View |
| 2026-03-05 Sale | 2026-03-06 4:08 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 2,732 | $14.9 | $40,707 | 446,145 (Indirect Direct) | View |
| 2025-12-05 Sale | 2025-12-05 4:11 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 2,662 | $20.72 | $55,157 | 268,877 (Indirect Direct) | View |
| 2025-12-05 Sale | 2025-12-05 4:09 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 880 | $20.72 | $18,234 | 87,510 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 4:08 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 144 | $20.72 | $2,984 | 94,729 (Direct) | View |
| 2025-09-05 Sale | 2025-09-09 4:31 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 2,640 | $13.41 | $35,402 | 271,539 (Indirect Direct) | View |
| 2025-09-04 Sale | 2025-09-08 4:06 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 1,038 | $13.29 | $13,794 | 94,873 (Direct) | View |
| 2025-09-04 Sale | 2025-09-08 4:03 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 4,425 | $13.3 | $58,842 | 88,390 (Direct) | View |
| 2025-07-14 Purchase | 2025-07-15 5:11 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 100,000 | $9.11 | $911,000 | 274,179 (Indirect Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:07 pm | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 4,060 | $13.35 | $54,201 | 174,179 (Indirect Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:05 pm | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 1,342 | $13.35 | $17,916 | 92,815 (Direct) | View |
| 2025-06-05 Sale | 2025-06-06 4:03 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 146 | $13.35 | $1,949 | 95,911 (Direct) | View |
| 2025-03-13 Sale | 2025-03-13 4:13 pm | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 143 | $12.12 | $1,733 | 96,057 (Direct) | View |
| 2025-03-11 Sale | 2025-03-13 4:08 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 1,343 | $11.38 | $15,283 | 122,330 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-12 Option Award | 2026-02-17 5:11 pm | N/A 2036-02-11 | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 465,000 | $0 | 733,877 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 5:10 pm | N/A 2036-02-11 | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 215,000 | $0 | 302,510 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 5:09 pm | N/A 2036-02-11 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 150,000 | $0 | 244,729 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-17 5:08 pm | N/A 2036-02-11 | Dyne Therapeutics Inc. | DYN | Lucera Erick Chief Financial Officer | 170,000 | $0 | 236,100 (Direct) | View |
| 2025-12-22 Option Award | 2025-12-23 4:08 pm | N/A 2035-12-21 | Dyne Therapeutics Inc. | DYN | Karnani Vikram Director | 59,665 | $0 | 59,665 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 4:18 pm | N/A 2035-09-30 | Dyne Therapeutics Inc. | DYN | Posner Brian S Director | 70,000 | $0 | 70,000 (Direct) | View |
Ownership | 2025-10-02 4:13 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Posner Brian S Director | 0 | $0 | 8,500 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:21 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Friedl-Naderer Johanna Chief Commercial Officer | 51,255 | $0 | 51,255 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:20 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Kerr Douglas Chief Medical Officer | 65,110 | $0 | 65,110 (Direct) | View |
| 2025-07-16 Option Award | 2025-07-18 5:19 pm | N/A 2035-07-15 | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 197,285 | $0 | 197,285 (Direct) | View |
| 2025-07-15 Gift | 2025-07-15 5:11 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 10,000 | $0 | 274,179 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:41 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | HURWITZ EDWARD Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:40 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Lubner David Charles Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:39 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:38 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:38 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Incerti Carlo Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-05-30 Option Award | 2025-06-03 9:37 pm | N/A 2035-05-29 | Dyne Therapeutics Inc. | DYN | Stehman-Breen Catherine Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2025-03-31 Option Award | 2025-04-01 4:33 pm | N/A 2035-03-30 | Dyne Therapeutics Inc. | DYN | Lucera Erick Chief Financial Officer | 280,600 | $0 | 280,600 (Direct) | View |